Trial intelligence / Profile preview

Topical Quixil vs intravenous tranexamic acid to reduce blood loss in primary hip and knee replacement

2006-001299-19Phase 4Completed

Sponsor
Golden Jubilee National Hospital
Start
Apr 2006
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial comparing Topical Quixil with Intravenous tranexamic acid (2 arms). Primary endpoint: Total blood loss from operation. Started Apr 2006; status: completed.

02

Drugs

quixiltranexamic acid

Beyond the preview

Go deeper on 2006-001299-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001299-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call